Johnson & Johnson (JNJ) Receivables (2009 - 2026)

Johnson & Johnson's Receivables history runs 18 years deep, the most recent figure standing at $17.7 billion for Q1 2026.

• In Q1 2026, Receivables rose 10.62% year-over-year to $17.7 billion; the TTM figure through Mar 2026 stood at $17.7 billion (up 10.62% YoY), while the FY2025 annual figure was $17.2 billion, up 15.74% from the prior year.
• Receivables came in at $17.7 billion for Q1 2026 at Johnson & Johnson, up from $17.2 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $17.8 billion in Q2 2025 to a low of $14.0 billion in Q1 2023.
• A 5-year average of $16.0 billion and a median of $16.0 billion in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables decreased 8.59% in 2024 and climbed 15.74% in 2025, its largest moves.
• Johnson & Johnson's Receivables stood at $15.9 billion in 2022, then slipped by 6.4% to $14.9 billion in 2023, then retreated by 0.21% to $14.8 billion in 2024, then increased by 15.74% to $17.2 billion in 2025, then advanced by 3.16% to $17.7 billion in 2026.
• According to Business Quant data, Receivables over the past three periods registered $17.7 billion, $17.2 billion, and $17.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison